Atricure Inc

NASDAQ:ATRC 4:00:00 PM EDT

32.77

+0.49 (+1.52%)

7:32:44 PM EDT: $33.44 +0.67 (+2.05%)

Market Cap (Intraday)	1.65B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$130.17 Million
Adjusted EPS	-$0.17

See more estimates

10-Day MA	$32.56
50-Day MA	$32.56
200-Day MA	$33.37

See more pivots

Atricure Inc Stock, NASDAQ:ATRC

7555 Innovation Way, Mason, Ohio 45040

United States of America

Phone: +1.513.755.4100

Number of Employees: 1300

http://www.atricure.com

Description

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.